Unity Biotechnology, Inc.UBXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank63
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P63
Within normal range
vs 2Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q1 2025 | 6.24% |
| Q4 2024 | -11.33% |
| Q3 2024 | 5.40% |
| Q2 2024 | 13.83% |
| Q1 2024 | -2.82% |
| Q4 2023 | 47.24% |
| Q3 2023 | -24.82% |
| Q2 2023 | -12.29% |
| Q1 2023 | 23.45% |
| Q4 2022 | -5.99% |
| Q3 2022 | -7.11% |
| Q2 2022 | 32.90% |
| Q1 2022 | -84.55% |
| Q4 2021 | 33.25% |
| Q3 2021 | 12.76% |
| Q2 2021 | -13.74% |
| Q1 2021 | 20.44% |
| Q4 2020 | 23.78% |
| Q3 2020 | -5.54% |
| Q2 2020 | 14.02% |
| Q1 2020 | -17.61% |
| Q4 2019 | -3.29% |
| Q3 2019 | 8.65% |
| Q2 2019 | -23.98% |
| Q1 2019 | 13.46% |
| Q4 2018 | -17.71% |
| Q3 2018 | 6.83% |
| Q2 2018 | -26.19% |
| Q1 2018 | -28.91% |
| Q4 2017 | -5.82% |
| Q3 2017 | -3.29% |
| Q2 2017 | -29.40% |
| Q1 2017 | 0.00% |